✦ LIBER ✦

Compensatory Increases in Her-2/neu Activation in Response to EGFR Tyrosine Kinase Inhibition in Colon Cancer Cell Lines

✍ Scribed by Peter A. Learn; Naveen Krishnegowda; Jose Talamantez; Morton S. Kahlenberg

Book ID: 116702740
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 519 KB
Volume: 136
Category: Article
ISSN: 0022-4804
DOI: 10.1016/j.jss.2006.07.046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activation of alternative HER receptors

Activation of alternative HER receptors mediates resistance to EGFR tyrosine kinase inhibitors in breast cancer cells

✍ A. Kong; V. Calleja; P. Leboucher; A. Harris; P. Parker; B. Larijani 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Her-2/neu and EGFR tyrosine kinase activ

Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer

✍ Gernot Hudelist; Wolfgang J. Köstler; Klaus Czerwenka; Ernst Kubista; Johannes A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 372 KB 👁 2 views

## Abstract Her‐2/__neu__ overexpression in human breast cancer leads to an aggressive biological behavior and poor prognosis. Although the anti‐Her‐2/__neu__ antibody trastuzumab (Herceptin®) has become a valuable therapeutic option for patients with Her‐2/__neu__‐overexpressing breast cancer, man

HGF/MET-mediated resistance to dual HER2

HGF/MET-mediated resistance to dual HER2 and EGFR kinase inhibition in HER2 amplified gastric cancer cells

✍ Chin-Tung Chen; David Liska; Martin R. Weiser 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 95 KB

485 POSTER Activation of alternative HER

485 POSTER Activation of alternative HER receptors mediates resistance to EGFR tyrosine kinase inhibitors in breast cancer cells

✍ A. Kong; V. Calleja; P. Leboucher; A. Harris; P. Parker; B. Larijani 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Activating and resistance mutations of E

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

✍ Gazdar, A F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB

The growth inhibitory effect of lapatini

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines

✍ Jin Won Kim; Hwang-Phill Kim; Seock-Ah Im; Soyeong Kang; Hyung Seok Hur; Young-K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 407 KB